Public, Private Players Should Share Genetic Test Oversight – HHS Advisers
This article was originally published in The Pink Sheet Daily
Executive Summary
Enhanced oversight of genetic tests should be shared through public/private partnerships, not just by extending FDA or CMS authority, HHS advisory committee says.
You may also be interested in...
NIH Genetic Testing Registry Aims To Shed Light Where Oversight Has Been Patchy
Voluntary registry falls short of the mandatory registration sought by advocates, HHS advisors and members of Congress.
NIH Genetic Testing Registry Aims To Shed Light Where Oversight Has Been Patchy
Voluntary registry falls short of the mandatory registration sought by advocates, HHS advisors and members of Congress.
Public Citizen's FDA? Lurie Is Consumer Group's Third In Key Agency Role
FDA's appointment of a high-profile consumer advocate to an Office of the Commissioner post continues a strategy of bringing some of the most outspoken critics of both the drug industry and its regulatory agency into FDA